Abiomed, Inc.

シンボルマーク: ABMD

NASDAQ

381.02

USD

今日の市場価格

126.8485
PER（株価収益率
-5.7181
PEGレシオ
17.18B
MRK キャップ
0.00%
DIV利回り

Abiomed, Inc. (ABMD) 財務諸表

Q: Abiomed, Inc.ABMD 総資産とは何ですか？

Abiomed, Inc. (ABMD) 総資産は .

Q: 企業のフリーキャッシュフローとは？

フリーキャッシュフローは .

Download

年次四半期

リニア対数

チャート上ではのダイナミクスにおけるデフォルトの数値を見ることができる。Abiomed, Inc. (ABMD). 会社の収益は NaN M の平均を示し、これは NaN % の成長率です。全期間の平均売上総利益は NaN M であり、NaN % である。平均売上総利益率は NaN % である。昨年度の純利益成長率はNaN % で, NaN % % に等しい。に等しい.,

年次四半期

10Y 20Y 30Y 40Y

貸借対照表

Abiomed, Inc.の財政の軌跡に飛び込むと、平均的な資産の伸びが観察される。この率は、興味深いことに、であり、会社の最高と最低の両方を反映している。前期比で比較すると、この数字はに調整される。過去1年間を振り返ってみると、総資産の変動は NaN となる. 総株主資本によって示される株主価値は、報告通貨でのNaN で評価される。この面の前年比変化はNaN% である.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995	1993	1991	1989	1987
balance-sheet.row.cash-and-short-term-investments	3092.52	758.6	583.7	443.1	491.7	362.2	229.9	212.1	132	76.6	76.7	77.2	60.3	58.3	57.2	38.3	75.1	30.8	41.5	27.3	54.4	71.3	92.5	106.4	18.2	26.4	9.4	10.6	0.6	0.5	0.7	4.7	8.1	24.6	10.4	13.3	2.4
balance-sheet.row.short-term-investments	2452.62	625.8	351	250.8	370.7	319.3	190.9	163.8	109.6	55.7	67.3	71.2	54.5	53.5	55.4	36.3	5.5	23	33.9	20.4	9.9	25.7	2	4.5	8.9	23.7	7.7	7.7	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	365.14	90.6	97.2	84.7	90.8	70	54.1	42.8	31.8	24.4	22.9	20.5	15.4	13.5	15.7	14.1	10.9	8.9	8.6	6	5.4	7.3	10	6.7	6.4	5.4	4.8	2.6	1.8	1.7	0.8	0.6	0.7	0.7	0.8	0.5	0.2
balance-sheet.row.inventory	381.79	94	81.1	90.1	80.9	50.2	34.9	26.7	16.8	13.9	14.9	11.1	7.5	9.2	14.8	17.4	8.6	4.9	3.9	2.7	2.9	4.2	3.7	3.5	2.9	2.3	1.8	1.7	1.4	2.2	1.5	0.9	1.2	1.1	0.9	0.6	0.4
balance-sheet.row.other-current-assets	145.19	33.3	26	18	13.7	11.8	8	6.8	39.6	3.1	2	1.7	1.5	1.7	0.8	1.7	1.8	1.9	1.2	1	0.9	0.8	0.8	0.5	0.3	0.2	0.2	0.1	3.9	2.7	9	13.8	14	0.2	0.1	0	0.4
balance-sheet.row.total-current-assets	3984.64	976.5	788	635.9	677.2	494.3	327	288.4	220.1	118	116.6	110.5	84.7	82.7	88.5	71.5	96.4	46.4	55.2	37	63.6	83.7	107	117.1	27.8	34.3	16.2	15	7.7	7.1	12	20	24	26.6	12.2	14.4	3.4
balance-sheet.row.property-plant-equipment-net	827.51	212	203.2	176.7	145	117.2	87.8	23.2	9.1	6.9	6.5	6.4	6.3	6.8	7.8	7.6	5.8	4.8	2.8	3.2	4	4.7	4.8	4	3.9	3.7	1.9	0.6	0.5	0.6	0.7	0.6	1.1	1.1	0.3	0.3	0.3
balance-sheet.row.goodwill	302.05	76.8	78.6	32	32.6	35.8	31	33	31.5	38	35.4	36.8	38.9	37.2	31.3	31.6	26.7	19.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	190.63	45.6	47.5	22.6	15.2	16.7	14.5	15.4	14.7	0	0	0.1	1.6	3	4.4	6.9	7.3	8.2	0.9	0.8	0.7	0	0	0	0	0	0	0	0	0.1	0.2	0.2	0.3	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	492.68	122.4	126	54.5	47.8	52.5	45.5	48.4	46.2	38	35.4	37	40.6	40.1	35.7	38.5	34	27.3	0.9	0.8	0.7	0	0	0	0	0	0	0	0	0.1	0.2	0.2	0.3	0	0	0	0
balance-sheet.row.long-term-investments	1311.42	351.9	365.7	302.2	21.7	37.5	47.1	1	14	41.8	11.4	0	0	0	3.7	0	0	0	2.1	18.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	50.21	10.6	11.4	43.3	77.5	70.7	34.7	58.5	45.2	0	0	0	0	0	0	0	0	0.3	-2.1	-18.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	0	0	0	3.8	85.1	14.2	8.3	4.4	3.7	0.8	0	0	0	0	0.3	0.5	0	-0.3	2.1	18.2	0	1.1	6.3	0.7	1.3	0.6	0.5	0.6	6.5	7.6	9.5	5	4.5	0	0	0	0
balance-sheet.row.total-non-current-assets	2681.81	696.9	706.4	580.6	377.1	292.1	223.5	135.5	118.2	87.4	53.4	43.4	46.9	46.9	47.5	46.5	39.8	32.1	5.8	22.2	4.8	5.8	11	4.6	5.1	4.3	2.4	1.2	7	8.3	10.4	5.8	5.9	1.1	0.3	0.3	0.3
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	6666.45	1673.4	1494.4	1216.5	1054.3	786.4	550.4	423.9	338.4	205.4	170	153.9	131.6	129.6	136	118	136.2	78.5	61.1	59.2	68.3	89.5	118	121.8	33	38.6	18.5	16.2	14.7	15.4	22.4	25.8	29.9	27.7	12.5	14.7	3.7
balance-sheet.row.account-payables	137.28	35.3	34.8	32.8	32.2	23.6	20.6	9.4	10.4	7.7	7.7	6.9	6.3	3.8	5.5	9	5.2	3.1	1.1	1.4	1.1	2	2.1	1.6	0.9	2.1	1.3	0.8	0.2	0.4	0.5	0.4	0.3	0	0	0	0
balance-sheet.row.short-term-debt	66.67	0	66	75.1	12.3	4.6	0.8	2.5	1.5	1.4	2.1	0.9	0	0	0	0	0	0	0	0	0	0.1	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-payables	20.02	1.9	5.9	21.6	12.3	4.6	3.2	2.5	1.5	1.4	2.1	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	0	0	0	0	0	0	15.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Non Current	0	0	0	0	0	0	-15.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	235.31	76.7	3.8	4.9	45.2	41.6	37.7	25.9	20.4	16.5	13.1	11.5	14.1	13	10.8	9.3	7	5.2	3.6	3.3	4.2	5.6	5.6	6.4	4.8	2.9	2	1.5	1.2	0.7	0.7	0.8	0.6	1.3	1.2	1.2	1.4
balance-sheet.row.total-non-current-liabilities	114.13	31.6	35.7	19.1	11.5	12.2	28.7	8.6	7.5	6.6	5.9	5.2	4.5	3.5	2.4	5	1.2	0.3	0	0	0	0	0.4	0.7	0.2	0.7	0	0	0	3.7	8.7	8.3	7.8	0	0	0	-0.1
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	0	0	0	0	0	0	16.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	654.2	170.1	164.7	151	117.5	96.9	98.3	55.2	46.8	37.1	32.9	27.6	26.8	21.6	20	24.4	14.1	9	4.9	4.8	6.2	10.2	9.3	8.9	5.9	5.6	3.3	2.3	1.4	4.8	9.9	9.5	8.7	1.3	1.2	1.2	1.3
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1.82	0.5	0.5	0.5	0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0
balance-sheet.row.retained-earnings	4012.96	964.5	828	602.5	399.5	140.5	-47	-99.1	-137.2	-250.9	-258.3	-273.3	-274.8	-263	-244	-212.4	-171.2	-143.3	-113.9	-111.5	-102.1	-84.4	-53.1	-41.7	-31.2	-24.5	-22	-22.8	-23.2	-22.9	-20.9	-17	-11.9	-5.3	-3.4	-1.1	-0.6
balance-sheet.row.accumulated-other-comprehensive-income-loss	-132.56	-27.2	-11.4	-11.2	-14.7	-4.2	-20.6	-14.5	-17.3	-0.7	-3.7	-1.8	0.7	-1	-1.7	5	0.6	-2.1	-0.3	-0.1	-8.6	3.1	3.1	-5.4	-3.9	-2.7	-2.6	-2.3	-2.1	-1.9	-1.6	-1.4	-1.1	-0.8	-0.7	-0.5	-0.3
balance-sheet.row.other-total-stockholders-equity	2130.03	565.5	512.7	473.7	551.7	552.8	519.2	482	445.7	419.6	398.7	400.9	378.4	371.6	361.3	300.7	292.4	214.6	170.1	165.7	172.5	160.4	158.4	159.9	62.1	60.2	39.8	39	38.6	35.4	35	34.7	34.2	32.5	15.4	15.1	3.3
balance-sheet.row.total-stockholders-equity	6012.25	1503.3	1329.7	1065.5	936.9	689.5	452.1	368.8	291.6	168.4	137.1	126.3	104.7	108	116	93.6	122.1	69.5	56.2	54.3	62.1	79.3	108.7	112.9	27.1	33	15.2	13.9	13.3	10.6	12.5	16.3	21.2	26.4	11.3	13.5	2.4
balance-sheet.row.total-liabilities-and-stockholders-equity	6666.45	1673.4	1494.4	1216.5	1054.3	786.4	550.4	423.9	338.4	205.4	170	153.9	131.6	129.6	136	118	136.2	78.5	61.1	59.2	68.3	89.5	118	121.8	33	38.6	18.5	16.2	14.7	15.4	22.4	25.8	29.9	27.7	12.5	14.7	3.7
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	6012.25	1503.3	1329.7	1065.5	936.9	689.5	452.1	368.8	291.6	168.4	137.1	126.3	104.7	108	116	93.6	122.1	69.5	56.2	54.3	62.1	79.3	108.7	112.9	27.1	33	15.2	13.9	13.3	10.6	12.5	16.3	21.2	26.4	11.3	13.5	2.4
balance-sheet.row.total-liabilities-and-total-equity	6666.45	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	3764.04	977.7	716.7	553	392.4	356.8	238.1	164.8	123.6	97.4	78.7	71.2	54.5	53.5	59.1	36.3	5.5	23	36	38.6	9.9	25.7	2	4.5	8.9	23.7	7.7	7.7	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-debt	0	0	0	0	0	0	16.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-debt	-639.9	-132.8	-232.7	-192.3	-121	-43	-22.7	-48.2	-22.4	-20.9	-9.5	-6	-5.8	-4.8	-1.8	-2	-69.6	-7.8	-7.6	-6.9	-44.6	-45.6	-90.2	-101.7	-9.3	-2.7	-1.6	-2.9	-0.6	-0.5	-0.7	-4.7	-8.1	-24.6	-10.4	-13.3	-2.4

キャッシュフロー計算書

Abiomed, Inc. の財務状況は、直近の期間においてフリー・キャッシュ・フローに顕著な変化が見られ、NaN の推移を示している。同社は最近、NaN を発行して株式資本を拡大し、前年度と比較してNaN の差を示した. 当社の投資活動は、報告通貨で NaN に相当する正味現金使用量をもたらしました。これは、NaN の前年からのシフトです. 同時期に、同社は NaN, NaN、および NaN を記録しており、同社の投資および返済戦略を理解する上で重要です. 財務活動によるキャッシュ・フローはNaN となり、前年同期との差はNaN となった。また、NaN を株主への配当に充当した。同時に、NaN と呼ばれるその他の財務操作も行っており、これらもこの期間のキャッシュフローに大きな影響を与えた. これらの要素を総合すると、会社の財務状況とキャッシュフロー管理に対する戦略的アプローチの包括的な絵が描かれる。

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995	1993	1991
cash-flows.row.net-income	266.76	136.5	225.5	203	259	112.2	52.1	38.1	113.7	7.4	15	1.5	-11.8	-19	-31.6	-40.9	-27.9	-29.4	-2.3	-9.4	-18.2	-21.7	-11.4	-10.5	-6.7	-2.5	0.7	0.5	-0.4	-2	-3.9	-5.1	-6.6
cash-flows.row.depreciation-and-amortization	27.56	28.1	24.1	20.4	14.1	11	6.2	3.3	2.8	2.5	2.7	4.3	3.9	4.9	5	6.1	3.9	2.7	1.2	1.4	1.7	1.8	3	1.7	1.4	0.9	0.4	0.3	0.4	0.3	0.3	0.6	0.3
cash-flows.row.deferred-income-tax	-13.2	2.4	29.4	33	-7.7	42.6	25.8	22.3	-87.1	0.9	0.8	0.8	1	1	0.7	0.5	0.5	0.3	-0.1	-0.1	-0.1	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	53.75	52.7	47	39.8	54.5	40.4	32.9	29.1	16.5	11.2	9.5	7.8	5.4	5.4	8.8	5.4	5.8	0.4	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-23.26	-30.2	-17.4	8	-38.8	-18.9	5.3	-15.6	-4.7	-0.5	-2.8	-11.7	0.5	3.6	-3.5	-8	-2.5	2.8	-4.1	-2.1	-0.2	-0.4	-3.5	1.5	-2.1	0.9	-1.4	-0.3	1.1	-1.8	-0.8	0.9	-0.7
cash-flows.row.account-receivables	-8.51	5.3	-12.1	5.6	-22	-15.3	-11.6	-10.9	-8	-1.3	-2.6	-5.3	-1.9	2.2	-2.5	-2.8	-1.9	0.3	-2.6	-0.6	1.5	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-36	-29.3	2.5	-13.2	-37.2	-15.7	-12.3	-11.5	-7	-0.6	-5.3	-6.2	-1.5	0.9	-1.6	-11.1	-4.1	-0.2	-1.2	0.2	1.4	-0.7	-0.1	-0.7	-0.6	-0.9	-0.2	-0.2	0.8	-0.7	-0.7	0.3	-0.1
cash-flows.row.account-payables	8.48	0.6	2.6	2.6	8	4.4	7.6	-2.6	3.4	-0.1	1.2	0.3	2.5	-1.4	-2.4	3.2	1.6	1.3	-0.2	0.3	-0.9	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	12.77	-6.8	-10.5	13.1	12.4	7.6	21.6	9.4	6.8	1.5	3.9	-0.5	1.4	1.8	3	2.6	2	1.4	-0.2	-2	-2.1	0.3	-3.4	2.1	-1.5	1.8	-1.2	0	0.3	-1.1	-0.1	0.6	-0.6
cash-flows.row.other-non-cash-items	-60.63	95.8	-34	10.7	-28.8	5.3	-7.2	-0.4	2.1	2.1	1.2	1	2.5	-3.1	2.2	8.1	0.3	13.9	0.1	0	0.5	0.3	0	0	0	0	0	0	-0.2	0.1	0.1	0.2	3
cash-flows.row.net-cash-provided-by-operating-activities	250.98	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-33.76	-35.8	-53.4	-44	-44	-55.9	-50.4	-15.6	-5.2	-2.8	-2.8	-1.7	-1.8	-1.8	-3.8	-3.8	-2.4	-3.1	-0.7	-0.4	-0.8	-1.6	-2.6	-1.4	-1.6	-16	-1.6	-0.3	-0.1	-0.2	-0.3	-0.1	-0.2
cash-flows.row.acquisitions-net	0	-82.8	-52.2	0	0	0	0	0	-15.7	0	0	1.7	3.8	4.6	5.6	0	0	-2.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	-745.81	-805.9	-582.3	-632.2	-404.3	-331.8	-281.4	-261.7	-100.5	-87.8	-49.4	-24.5	-8	-11.9	-60.2	-66.4	-17.7	-29	-39.5	-39	-14.6	-38	-27	-8.3	-25.5	0	0	0	-1.3	-2.9	-4.3	0	0
cash-flows.row.sales-maturities-of-investments	616.66	543.5	464.5	550.8	331.9	206.9	205.5	219.6	71.5	68.3	42	8.8	7	17.8	37.1	34.5	35.2	42	42.2	10.2	30.4	14.4	29.4	12.7	40.4	0	0	2.7	0	6.2	4.9	0	5.5
cash-flows.row.other-investing-activites	0	0	0	0	0	0	0	0	0	0	0	-1.7	-3.4	0	-5.6	-5.1	0	0	0	0	-0.1	0	0	0	0	-2.5	0	-0.8	0.7	0	0.1	0	-0.1
cash-flows.row.net-cash-used-for-investing-activites	-162.91	-381	-223.3	-125.5	-116.5	-180.8	-126.3	-57.7	-49.9	-22.3	-10.3	-17.5	-2.4	8.8	-26.8	-40.9	15.1	7.4	1.9	-29.2	14.8	-25.2	-0.1	3.1	13.3	-18.5	-1.6	1.6	-0.7	3.1	0.4	-0.1	5.2
cash-flows.row.debt-repayment	0	0	0	0	0	-0.5	-0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-issued	10.35	7.2	5.5	5.1	3.1	2.4	1.7	1.1	0.8	-0.3	-0.3	0.4	0.3	0.3	42.2	3.9	66.6	2.2	4.1	1.6	0.3	1	0.9	96.3	0.8	20.3	0.5	0.1	0	0.1	0.1	0.1	1.4
cash-flows.row.common-stock-repurchased	-126.62	0	-11.3	-84.9	0	0	0	0	0	-0.4	-15.3	0	0	0	0	-1.9	-0.1	-0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	-19.26	-9.4	-2.2	-37.9	-58.8	-11	2.6	6	8.7	10.3	3.7	14.3	1.1	0.6	4	0	0	0	0	0	-0.1	-0.5	-0.2	0.6	0	0	0	0	0	0	-0.1	0	0
cash-flows.row.net-cash-used-provided-by-financing-activities	-135.53	-2.2	-8.1	-117.7	-55.8	-9.1	3.9	7.2	9.5	9.6	-11.8	14.7	1.4	1	46.2	2.1	66.6	2.1	4.1	1.6	0.3	0.5	0.6	96.9	0.8	20.3	0.5	0.1	0	0.1	0	0.1	1.4
cash-flows.row.effect-of-forex-changes-on-cash	-12.08	-2.1	-2.8	-0.4	-1.9	1.3	-1.8	-0.4	-1.5	0.6	-0.9	-0.7	0.4	0.6	-1.4	0.1	0	0.1	-0.1	0.1	0	0	0	0	0	0	0	0	0	0.3	0	3.5	-1.2
cash-flows.row.net-change-in-cash	-59.55	-99.9	40.4	71.3	78	3.9	-9.2	25.8	1.5	11.5	3.5	0.2	1	3	-0.3	-67.6	61.8	0.2	0.8	-37.7	-1.1	-44.8	-11.5	92.6	6.6	1.1	-1.3	2.3	0.2	0.1	-3.9	0.1	1.4
cash-flows.row.cash-at-end-of-period	639.9	132.8	232.7	192.3	121	43	39	48.2	22.4	20.9	9.5	6	5.8	4.8	1.8	2	69.6	7.8	7.6	6.9	44.6	45.7	90.5	101.9	9.3	2.7	1.6	2.9	0.7	0.8	0.8	8.1	6.8
cash-flows.row.cash-at-beginning-of-period	699.45	232.7	192.3	121	43	39	48.2	22.4	20.9	9.5	6	5.8	4.8	1.8	2	69.6	7.8	7.6	6.8	44.6	45.7	90.5	101.9	9.3	2.7	1.6	2.9	0.6	0.5	0.7	4.7	8	5.4
cash-flows.row.operating-cash-flow	250.98	285.4	274.6	314.9	252.2	192.5	115.1	76.8	43.3	23.5	26.4	3.6	1.6	-7.4	-18.3	-28.9	-19.8	-9.3	-5.2	-10.1	-16.2	-20.1	-12	-7.3	-7.4	-0.7	-0.2	0.6	0.9	-3.4	-4.3	-3.4	-4
cash-flows.row.capital-expenditure	-33.76	-35.8	-53.4	-44	-44	-55.9	-50.4	-15.6	-5.2	-2.8	-2.8	-1.7	-1.8	-1.8	-3.8	-3.8	-2.4	-3.1	-0.7	-0.4	-0.8	-1.6	-2.6	-1.4	-1.6	-16	-1.6	-0.3	-0.1	-0.2	-0.3	-0.1	-0.2
cash-flows.row.free-cash-flow	217.22	249.6	221.2	270.9	208.2	136.7	64.7	61.2	38.1	20.7	23.6	1.9	-0.2	-9.2	-22.1	-32.7	-22.2	-12.4	-5.9	-10.6	-17	-21.7	-14.5	-8.7	-9	-16.7	-1.8	0.2	0.8	-3.6	-4.6	-3.5	-4.2

損益計算書の行

Abiomed, Inc. の売上は前期比 NaN% の変化。ABMD の売上総利益は NaN と報告されている。同社の営業費用は NaN で、前期比NaN% の変化を示している. 減価償却費は NaN であり、前期からの増減率は NaN% である。営業費用は NaN と報告されており、前年比NaN% の変化を示している。販売・マーケティング費用は NaN で、前年度比 NaN% の変化である。直近の数字に基づくEBITDAは NaN で、前年比NaN% の伸びを示す。営業利益は NaN で、前年度比NaN% の変化を示している。当期純利益の増減率は NaN%。前年度の当期純利益は NaN であった。

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995	1993	1991	1989	1987
income-statement-row.row.total-revenue	1074.1	1031.8	847.5	840.9	769.4	593.7	445.3	329.5	230.3	183.6	158.1	126.4	101.2	85.7	73.2	58.9	50.6	43.7	38.2	25.7	23.3	26.9	24.9	22.5	22.1	22.4	16.5	12.8	9.2	6.7	3.4	2.7	2	3	2.9	4.2	4.7
income-statement-row.row.cost-of-revenue	200.59	188.2	161.9	151.3	129.6	98.6	70.6	50.4	39.9	37.3	31.6	24.5	22	22.5	20.4	15.1	12	11.7	9.4	7.6	7.5	7.9	7.4	5.9	6.8	6.5	5.4	3.9	2.9	1.9	3	2	1.3	1	1.1	0.2	3.7
income-statement-row.row.gross-profit	873.51	843.6	685.6	689.6	639.9	495.2	374.7	279.1	190.4	146.3	126.5	101.9	79.2	63.2	52.8	43.9	38.6	32	28.9	18.1	15.8	18.9	17.5	16.6	15.3	15.9	11.1	8.9	6.3	4.8	0.4	0.7	0.7	2	1.8	4	1
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	167.22	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-7.58	0	51.9	-4.6	30.4	-0.4	-0.3	0.3	-0.1	0	0.3	1.5	1.4	1.5	1.6	2.8	1.6	1.3	13.2	13.6	20.4	0	0	0	0	-1.2	0	0	0.4	0.3	0.3	0.6	0.3	0.2	0.2	0.2	0.2
income-statement-row.row.operating-expenses	619.4	586.9	456.1	440.4	415.1	338	284.5	214	161.7	138	110	100.3	90.4	88.3	82.3	80.4	66.3	62.3	32.1	28.4	35.3	43.6	35.1	28.2	23.2	16.9	10.9	9	7.2	7.1	4.9	7	9.1	5.4	5	5.3	1.1
income-statement-row.row.cost-and-expenses	819.99	775	618	591.7	544.6	436.6	355.2	264.4	201.6	175.3	141.6	124.9	112.3	110.8	102.7	95.4	78.4	74	41.5	36	42.8	51.5	42.5	34.1	30	23.4	16.3	12.9	10.1	9	7.9	9	10.4	6.4	6.1	5.5	4.8
income-statement-row.row.interest-income	94.24	49.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	94.24	49.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	87.06	-182.1	58.7	7.6	38.5	3.3	1.2	0.7	0.1	0.2	0.3	1	0.3	6.7	-1.3	-5.1	0.3	0	0.1	0.2	0.2	0	0	0	0	0	0	0	0.4	0.4	0.6	1.2	1.7	1.5	0.9	0.7	0.2
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-7.58	0	51.9	-4.6	30.4	-0.4	-0.3	0.3	-0.1	0	0.3	1.5	1.4	1.5	1.6	2.8	1.6	1.3	13.2	13.6	20.4	0	0	0	0	-1.2	0	0	0.4	0.3	0.3	0.6	0.3	0.2	0.2	0.2	0.2
income-statement-row.row.total-operating-expenses	87.06	-182.1	58.7	7.6	38.5	3.3	1.2	0.7	0.1	0.2	0.3	1	0.3	6.7	-1.3	-5.1	0.3	0	0.1	0.2	0.2	0	0	0	0	0	0	0	0.4	0.4	0.6	1.2	1.7	1.5	0.9	0.7	0.2
income-statement-row.row.interest-expense	94.24	49.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.depreciation-and-amortization	30.48	28.1	17.4	8.3	14.1	11	6.2	3.3	2.8	2.5	2.7	4.3	3.9	4.9	5	6.1	3.9	2.7	1.2	1.4	1.7	1.8	3	1.7	1.4	0.9	0.4	0.3	0.4	0.3	0.3	0.6	0.3	0.2	0.2	0.2	0.2
income-statement-row.row.ebitda-caps	284.19	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	253.61	372.7	229.6	249.2	224.8	157.1	90.1	65.1	28.7	8.4	16.5	1.5	-11.2	-25.1	-29.5	-36.5	-28.5	-30.3	-3.3	-10.3	-19.5	-24.6	-17.6	-11.6	-7.9	-1	0.2	0	-0.9	-2.3	-4.5	-6.3	-8.4	-3.4	-3.2	-1.3	-0.1
income-statement-row.row.income-before-tax	341.16	190.6	288.2	256.8	263.4	160.4	91.3	65.8	28.8	8.5	16.9	2.5	-10.9	-18.4	-30.8	-40.4	-27.4	-29.1	-2.3	-9.4	-18.2	0	0	0	0	0	0	0	-0.5	-1.9	-3.9	-5.1	-6.7	-1.9	-2.3	-0.6	0.1
income-statement-row.row.income-tax-expense	74.4	54.1	62.7	53.8	4.3	48.3	39.2	27.7	-84.9	1.2	1.8	1	0.9	0.7	0.8	0.5	0.5	0.4	0.1	0.2	0.2	-2.9	-6.2	-1.1	-1.2	1.5	-0.5	-0.5	-0.5	0.4	0.6	1.2	1.7	1.5	0.9	0.7	0.2
income-statement-row.row.net-income	266.76	136.5	225.5	203	259	112.2	52.1	38.1	113.7	7.4	15	1.5	-11.8	-19	-31.6	-40.9	-27.9	-29.4	-2.3	-9.4	-18.2	-21.7	-11.4	-10.5	-6.7	-2.5	0.7	0.5	-0.4	-2	-3.9	-5.1	-6.6	-1.9	-2.2	-0.6	0.1